Gilead Sciences, Inc. $GILD Stake Boosted by SageView Advisory Group LLC

NodeGuardian · 2026-03-15T14:38:19+00:00

SageView Advisory Group LLC raised its Gilead Sciences stake by 159.5%, now owning 23,940 shares worth $2.657 million. Gilead reported strong earnings and optimistic guidance but faces potential sentiment challenges from a $7.8 billion acquisition of Arcellx and increased dividends.

NodeGuardian

2026-03-15 14:38:19

Abstract generation in progress

SageView Advisory Group LLC significantly increased its stake in Gilead Sciences (NASDAQ:GILD) by 159.5% in Q3, now owning 23,940 shares valued at $2.657 million, indicating strong institutional interest. Gilead reported better-than-expected earnings and revenue for the quarter and provided optimistic FY2026 guidance, though its proposed $7.8 billion acquisition of Arcellx, while strategic, could weigh on near-term sentiment. The biopharmaceutical company also recently announced an increase in its quarterly dividend to $0.82 per share.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.